COMPANY

DemeRx

Keywords: alcohol use disorder

Profile checked Oct 10, 2026

NIH awards 2

Annual award amounts. Total $1.7M.

Jul 23, 2026 NIH award 5R43AA032127-02 FY2026: $796,298 awarded for that fiscal year; activity R43 (SBIR); PI MASH, DEBORAH C.; recipient as written: DEMERX, INC., MIAMI, FL. Investigational New Drug Development of Noribogaine fo source ↗
Jul 23, 2025 NIH award 1R43AA032127-01 FY2025: $914,324 awarded for that fiscal year; activity R43 (SBIR); PI MASH, DEBORAH C.; recipient as written: DEMERX, INC., MIAMI, FL. Investigational New Drug Development of Noribogaine fo source ↗

NIH award NIH awarded $796K (SBIR Phase I 5R43AA032127-02, continuation, notice Jul 23, 2026). NIH RePORTER 5R43AA032127-02 (Jul 23, 2026)
Evidence (1 event)
- Jul 23, 2026 · NIH RePORTER 5R43AA032127-02
  Organization: DEMERX, INC.; City/State: MIAMI, FL; Project number: 5R43AA032127-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-23; FY total cost (award amount): 796298; Administering IC: National Institute on Alcohol Abuse and Alcoholism; Project title: Investigational New Drug Development of Noribogaine for Alcohol Use Disorder; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals